BrightSpring Health Services, Inc. (NASDAQ:BTSG – Get Free Report) has earned an average rating of “Buy” from the twenty analysts that are presently covering the stock, Marketbeat.com reports. Eighteen equities research analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $70.7059.
Several equities analysts have recently commented on BTSG shares. BTIG Research reaffirmed a “buy” rating and issued a $90.00 price target on shares of BrightSpring Health Services in a research note on Monday, August 3rd. Zacks Research upgraded shares of BrightSpring Health Services from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 4th. Morgan Stanley upped their target price on shares of BrightSpring Health Services from $71.00 to $80.00 and gave the company an “overweight” rating in a research report on Tuesday, July 14th. Wells Fargo & Company increased their target price on shares of BrightSpring Health Services from $61.00 to $78.00 and gave the stock an “overweight” rating in a research note on Monday, July 13th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $70.00 target price on shares of BrightSpring Health Services in a research note on Monday, August 3rd.
View Our Latest Report on BTSG
BrightSpring Health Services Stock Up 3.1%
BrightSpring Health Services (NASDAQ:BTSG – Get Free Report) last issued its quarterly earnings data on Friday, July 31st. The company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.05. BrightSpring Health Services had a return on equity of 16.73% and a net margin of 2.55%.The company had revenue of $3.87 billion during the quarter, compared to analyst estimates of $3.66 billion. During the same period in the prior year, the business posted $0.22 earnings per share. The firm’s revenue for the quarter was up 23.0% compared to the same quarter last year. On average, equities research analysts anticipate that BrightSpring Health Services will post 1.78 EPS for the current year.
Insider Activity at BrightSpring Health Services
In related news, insider Lisa A. Nalley sold 35,000 shares of the stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $58.75, for a total transaction of $2,056,250.00. Following the completion of the transaction, the insider owned 131,948 shares of the company’s stock, valued at approximately $7,751,945. This trade represents a 20.96% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Jon B. Rousseau sold 130,000 shares of the stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $58.75, for a total transaction of $7,637,500.00. Following the transaction, the insider directly owned 1,194,503 shares of the company’s stock, valued at $70,177,051.25. The trade was a 9.82% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 2.80% of the company’s stock.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently modified their holdings of BTSG. Vanguard Group Inc. lifted its stake in BrightSpring Health Services by 30.5% during the 4th quarter. Vanguard Group Inc. now owns 12,533,656 shares of the company’s stock worth $469,385,000 after acquiring an additional 2,928,953 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in BrightSpring Health Services by 4.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 10,662,236 shares of the company’s stock valued at $399,302,000 after acquiring an additional 478,436 shares during the period. Invesco Ltd. grew its position in BrightSpring Health Services by 13.4% in the 4th quarter. Invesco Ltd. now owns 10,595,232 shares of the company’s stock valued at $396,791,000 after acquiring an additional 1,248,107 shares in the last quarter. T. Rowe Price Investment Management Inc. grew its position in BrightSpring Health Services by 21.7% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 6,123,865 shares of the company’s stock valued at $229,339,000 after acquiring an additional 1,091,757 shares in the last quarter. Finally, Alliancebernstein L.P. increased its stake in BrightSpring Health Services by 12.1% during the second quarter. Alliancebernstein L.P. now owns 5,450,085 shares of the company’s stock worth $128,568,000 after purchasing an additional 588,642 shares during the period.
About BrightSpring Health Services
BrightSpring Health Services (NASDAQ: BTSG) is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company’s operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.
Through its network of subsidiary brands, BrightSpring offers integrated care in the patient’s home environment, fostering independence and improving quality of life.
Recommended Stories
- Five stocks we like better than BrightSpring Health Services
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Receive News & Ratings for BrightSpring Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrightSpring Health Services and related companies with MarketBeat.com's FREE daily email newsletter.
